Skip to main content
. 2022 Sep 7;10(9):1491. doi: 10.3390/vaccines10091491

Figure 4.

Figure 4

Nitrite release from DCs following treatment with MP. Cell density was adjusted to 3 × 104 cells/well and then treated with the following groups for 24 h: No Treatment (-ve control), iCCoV suspension (2 μg), iCCoV MP (2 μg), Alhydrogel® MP (3 μg), AddaVax™ (0.5 μg), iCCoV MP (2 μg) + Alhydrogel® MP (3 μg), iCCoV MP (2 μg) + AddaVax™ (0.5 μg) MP, iCCoV MP (2 μg) + Alhydrogel® MP (2 μg) + AddaVax™ (0.5 μg) MP. The nitrite release in the supernatant was assessed using the Griess assay. Data are expressed as mean ± SEM (n = 3), One-way ANOVA test, Post hoc Dunnett’s multiple comparisons test, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, and **** p ≤ 0.0001.